Prevalence and clinical-pathological features of nevus-associated versus de novo melanoma: a retrospective cross-sectional study of 2806 cases
Keywords:
melanoma, nevus-associated melanoma, de novo melanomaAbstract
Introduction: Nevus-associated melanoma (NAM) accounts for almost one third of all cutaneous melanomas; it is often associated with younger age, trunk location and lower Breslow’s thickness compared to de novo melanoma (DNM).
Objectives: To define the prevalence of NAM in a tertiary referral Center in Italy and to analyze its distribution according to demographics, clinical and histopathological variables
Methods: Data were retrospectively retrieved from the archive of the Pathology Unit from June 2011 to August 2020. NAMs were compared with DNMs according to demographic, clinical and histopathological variables.
Results: A total of 2806 consecutive cases of melanoma were excised in 2537 patients. Of these, 431 (15.4%) were NAM. NAM patients were significantly younger than DNM patients (55.1±14.1 vs. 62.0±15.0 years, p<0.001); they were predominantly located on the trunk (64.0% vs. 47.9% of DNMs). Melanoma located on the head and neck, trunk and upper limbs respectively had 2.3 (95%CI:1.2-4.5, p:0.014), 3.2 (95%CI:2.1-5.1, p<0.001) and 3.5 (95%CI:2.0-6.1, p<0.001) more odds to be NAM than those on the lower limbs.
Conclusions: Our results confirm the association of NAM with younger age and trunk location. We also demonstrated that body site differences of NAM distribution are enhanced before the sixth decade of life.
References
2. Pandeya N, Kvaskoff M, Olsen CM, et al. Factors Related to Nevus-Associated Cutaneous Melanoma: A Case-Case Study. J Invest Dermatol. 2018 Aug;138(8). DOI: 10.1016/j.jid.2017.12.036. PMID: 29524457
3. Longo C, Rito C, Beretti F, et al. De novo melanoma and melanoma arising from pre-existing nevus: In vivo morphologic differences as evaluated by confocal microscopy. J Am Acad Dermatol. 2011 Sep;65(3). DOI: 10.1016/j.jaad.2010.10.035. PMID: 21715047
4. Haenssle HA, Mograby N, Ngassa A, et al. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas. JAMA Dermatol. 2016 Mar 1;152(3). DOI: 10.1001/jamadermatol.2015.3775. PMID: 26536613
5. Pampena R, Pellacani G, Longo C. Nevus-Associated Melanoma: Patient Phenotype and Potential Biological Implications. J Invest Dermatol. 2018 Aug;138(8). DOI: 10.1016/j.jid.2018.01.025. PMID: 30032788
6. Cymerman RM, Shao Y, Wang K, et al. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival. J Natl Cancer Inst. 2016 Oct 27;108(10). DOI: 10.1093/jnci/djw121. PMID: 27235387
7. Massi D, Carli P, Franchi A, Santucci M. Naevus-associated melanomas. Melanoma Res. 1999 Feb;9(1). DOI: 10.1097/00008390-199902000-00011. PMID: 10338338
8. Pampena R, Lai M, Piana S, Lallas A, Pellacani G, Longo C. Nevus-associated melanoma: Facts and controversies. G Ital Dermatol Venereol. 2020;155(1). DOI: 10.23736/S0392-0488.19.06534-9. PMID: 32100974
9. Kaddu S, Smolle J, Zenahlik P, Hofmann-Wellenhof R, Kerl H. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis. Melanoma Res. 2002 Jun;12(3). DOI: 10.1097/00008390-200206000-00011. PMID: 12140384
10. Whiteman DC, Pavan WJ, Bastian BC. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res. 2011 Oct;24(5). DOI: 10.1111/j.1755-148X.2011.00880.x. PMID: 21707960
Published
Issue
Section
License
Copyright (c) 2022 Caterina Longo, Michela Lai, Simonetta Piana, Giovanni Pellacani, Riccardo Pampena
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
